Tonix Pharmaceuticals Holding Corporation

1:30 PM - 1:45 PM, Tuesday, June 4,2019 ・ Theater 2
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) is a clinical-stage biopharmaceutical company committed to discovering and developing innovative and proprietary new therapeutics. Our current focus is on neuropsychiatric disorders and biodefense technologies. Our mission is to improve the lives of patients by identifying, researching and developing promising therapies which have the potential to address needs not currently fulfilled by existing products.
Speaker
photo
CEO
Tonix Pharmaceuticals Holding Corp.